Carmat
Pre-clinicalCarmat develops and manufactures a fully artificial heart for patients with end-stage biventricular heart failure.
Founded
2008
Focus
CardiovascularMedical Devices
About
Carmat develops and manufactures a fully artificial heart for patients with end-stage biventricular heart failure.
Funding History
4Total raised: $75M
PIPE$50MUndisclosedJun 15, 2017
IPOUndisclosedUndisclosedDec 20, 2010
Series B$15MUndisclosedJun 15, 2010
Series A$10MUndisclosedJun 15, 2008
Company Info
TypePrivate
Founded2008
LocationVélizy-Villacoublay, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile